Skip to main content
. 2018 Feb 5;20(9):1231–1239. doi: 10.1093/neuonc/noy015

Fig. 4.

Fig. 4

Time to progression for Evo/Bev compared with prior regimens by patient. Black = external beam radiotherapy/temozolomide; dark gray = Bev; light gray = Evo/Bev.